Market News
Latest news from Stock markets.
Is Gap Positioned to Extend Its Q3 Sales Momentum as Key Brands Shine?
GAP posts its strongest comps in years as Old Navy, Gap and Banana Republic fuel a sales surge and lift its fiscal 2025 outlook.
...keep reeding on zacks.com
BNY Mellon Stock Hits 52-Week High: Is This the Right Time to Invest?
BK shares hit a 52-week high as rising revenues, global expansion and solid capital strength fuel optimism despite cost and fee-income pressure.
...keep reeding on zacks.com
Netflix to Buy Warner Brothers for $72 Billion, PCE Data Delayed
Netflix streaming services will now join CNN, HBO Max, Major League Baseball, DC Studios, the Food Network and HGTV, to name just a few.
...keep reeding on zacks.com
NJDCY INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Nidec To Contact Him Directly To Discuss Their Options If you suffered significant losses in Nidec stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 5, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nidec Corporation ("Nidec" or the "Company") (OTC: NJDCY).
...keep reeding on newsfilecorp.com
KNOT Offshore Partners LP Common Units (KNOP) Q3 2025 Earnings Call Transcript
KNOT Offshore Partners LP Common Units ( KNOP ) Q3 2025 Earnings Call December 5, 2025 9:30 AM EST Company Participants Derek Lowe - CEO & CFO Conference Call Participants Charles Fratt - Alliance Global Partners, Research Division Presentation Operator Ladies and gentlemen, thank you for joining us, and welcome to the KNOP Third Quarter 2025 Earnings Call. [Operator Instructions] I will now hand the conference over to Derek Lowe.
...keep reeding on seekingalpha.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Freeport-McMoran
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Freeport-McMoran To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Freeport between February 15, 2022 and September 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 5, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Freeport-McMoran Inc. ("Freeport" or the "Company") (NYSE: FCX) and reminds investors of the January 12, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on newsfilecorp.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Telix between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ: TLX) and reminds investors of the January 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Firefly
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Firefly Aerospace to Contact Him Directly to Discuss Their Options If you purchased or otherwise acquired: (a) Firefly common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about August 7, 2025 (the "IPO" or "Offering"); and/or (b) Firefly securities between August 7, 2025 and September 29, 2025, both dates inclusive (the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 5, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Firefly Aerospace Inc. ("Firefly" or the "Company") (NASDAQ: FLY) and reminds investors of the January 12, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on newsfilecorp.com
Best Momentum Stocks to Buy for Dec.5
CRDO, AEO and MH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Dec. 5, 2025.
...keep reeding on zacks.com
What Does Netflix's Planned Acquisition Of Warner Bros. Mean For Theaters And Titles Like HBO, CNN?
Netflix announced Friday morning it struck a deal with Warner Bros. to purchase the storied film studio for $82.7 billion, a potentially major acquisition that shook the film and television industries.
...keep reeding on forbes.com
New Energy Equity's Lift As We Climb Foundation Raises $143,000 for Let's Share the Sun Foundation at 4th Annual Charity Golf Tournament
ANNAPOLIS, Md. , Dec. 5, 2025 /PRNewswire/ -- New Energy Equity and its Lift As We Climb Foundation (LAWC) raised $143,000 to support Let's Share the Sun Foundation (LSTS), a nonprofit dedicated to bringing solar energy to underserved communities.
...keep reeding on prnewswire.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In MoonLake To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in MoonLake between March 10, 2024 and September 29, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Reuters Research Inc. ("MoonLake" or the "Company") (NASDAQ: MLTX) and reminds investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Skye to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Skye between November 4, 2024 and October 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 5, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Skye Biosciences, Inc. ("Skye" or the "Company") (NASDAQ: SKYE) and reminds investors of the January 16, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on newsfilecorp.com
Reko International Group Inc. Declares Cash Dividend
WINDSOR, Ontario--(BUSINESS WIRE)--Reko International Group Inc. (TSX-V: REKO) today announced that its Board of Directors has declared a cash dividend of $0.20 per common share, payable on January 16, 2026 to shareholders of record on December 16, 2025. The ex-dividend date will be December 13, 2025. Shareholders are asked to ensure that Odyssey Trust Company has their up-to-date contact information, including mailing address, in order to expediate the payment of the dividend. Neither TSX Vent.
...keep reeding on businesswire.com
ASTS Shares Zoom on Upcoming BlueBird 6 Launch: Worth Buying Now?
ASTS jumps 18.3% ahead of BlueBird 6 launch as investors eye its next-gen satellite and major carrier deals.
...keep reeding on zacks.com
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses in Tvardi to Contact Him Directly to Discuss Their Options If you suffered significant losses in Tvardi stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 5, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc. ("Tvardi" or the "Company") (NASDAQ: TVRD).
...keep reeding on newsfilecorp.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Baxter Investors Have Opportunity to Lead Class Action Lawsuit
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Baxter between February 23, 2022 and October 29, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) and reminds investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
Rubrik surges on strong Q3 earnings, guidance raise
Rubrik (NYSE:RBRK) reported third-quarter results that significantly exceeded Wall Street expectations, sending shares up nearly 24% in early trading on Friday. The cybersecurity company posted revenue of $350.2 million, up 48% from a year earlier and above analysts' estimate of $321 million.
...keep reeding on proactiveinvestors.com
Laurentian Bank of Canada (LB:CA) Q4 2025 Earnings Call Transcript
Laurentian Bank of Canada (LB:CA) Q4 2025 Earnings Call Transcript
...keep reeding on seekingalpha.com
PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript
PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript
...keep reeding on seekingalpha.com
KBR Secures $117M U.S. Navy Contract to Support Global F/A-18 Fleet
KBR lands a $117M U.S. Navy deal to bolster global F/A-18 support, boosting its defense reach and lifting shares after the announcement.
...keep reeding on zacks.com
Biotech ETF (XBI) Hits New 52-Week High
XBI hits a 52-week high, climbing 85% from its low, as biotech gains momentum from AI adoption and favorable market trends.
...keep reeding on zacks.com
Capturing AI Gains Without Overexposure: ETFs to Consider
As AI continues to power market momentum, a diversified approach is key. Here are some ETFs that can help investors benefit from the AI rally without overexposure.
...keep reeding on zacks.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. ("Inspire Medical" or the "Company") (NYSE: INSP) and reminds investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
Exclusive: Swiss government set to water down part of UBS capital rules, sources say
The Swiss government is set to soften part of a banking regulation package that could force UBS to add as much as $24 billion in capital, three people familiar with the matter said.
...keep reeding on reuters.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CarMax
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in CarMax to Contact Him Directly to Discuss Their Options If you suffered losses in CarMax between June 20, 2025 and September 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 5, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against CarMax, Inc. ("CarMax" or the "Company") (NYSE: KMX) and reminds investors of the January 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on newsfilecorp.com
The New York Times is suing Perplexity for copyright infringement
The New York Times filed suit Friday against AI search startup Perplexity for copyright infringement, its second lawsuit against an AI company. The Times joins several media outlets suing Perplexity, including the Chicago Tribune, which also filed suit this week.
...keep reeding on techcrunch.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Stride
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Stride To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Stride between October 22, 2024 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Stride, Inc. ("Stride" or the "Company") (NYSE: LRN) and reminds investors of the January 12, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
Denali Enters Into a $275M Funding Deal With Royalty Pharma
DNLI secures a $275M funding deal with Royalty Pharma tied to potential approvals for its Hunter syndrome therapy.
...keep reeding on zacks.com
Can Galafold Continue to Drive Amicus' Top Line in 2026?
FOLD leans on rising Galafold sales on the back of strong commercial execution as momentum builds into 2026.
...keep reeding on zacks.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Primo Brands
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Primo Brands To Contact Him Directly To Discuss Their Options If you purchased or acquired securities: (a) the common stock of Primo Water between June 17, 2024 through November 8, 2024, inclusive, and/or (b) the common stock of Primo Brands between November 11, 2024 through November 6, 2025, inclusive (collectively, the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 5, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Primo Brands Corporation ("Primo Brands" or the "Company") (NYSE: PRMB) and reminds investors of the January 12, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on newsfilecorp.com
Martin Midstream Partners L.P. to Participate in the Wells Fargo 24th Annual Energy and Power Symposium
KILGORE, Texas--(BUSINESS WIRE)--Martin Midstream Partners L.P. (NASDAQ: MMLP) announced today that members of executive management will participate in meetings with investors at the Wells Fargo 24th Annual Energy and Power Symposium on Tuesday, December 9, 2025 in New York City. The latest investor presentation can be accessed under the Investor Relations tab on the Martin website. Martin Midstream Partners L.P., headquartered in Kilgore, Texas, is a publicly traded limited partnership with a.
...keep reeding on businesswire.com
Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
NEW YORK, NY / ACCESS Newswire / December 5, 2025 / The market tends to categorize companies by the sector in which they operate. Gold companies go in one box.
...keep reeding on accessnewswire.com
Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement
ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced the highly anticipated market launch of its flagship nutraceutical, Maxasome™ . Derived exclusively from 100% pure Exosome-Like Nanoparticles (ELNs) extracted from the high-value Yellow Oyster Mushroom (Pleurotus citrinopileatus), Maxasome™ is an unprecedented, all-natural, multi-modal cytoprotective agent designed to deliver unparalleled cellular defense and extend health span.
...keep reeding on accessnewswire.com
Salesforce Data: AI and Agents Propel Cyber Week to Record $336.6B in Global Spend
SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world's #1 AI CRM, today unveiled its 2025 Cyber Week results (November 25–December 1), analyzing shopping data from over 1.5 billion shoppers. This was another record-breaking shopping week, with overall industry global sales increasing 7% year over year (YOY) to $336.6 billion, and U.S. sales accounting for $79.6 billion (up 5% YOY). These results signal a strong consumer appetite for buying this holiday season despite increasing glo.
...keep reeding on businesswire.com
Absecon Bancorp Declares Fourth-Quarter Cash Dividend of $1.05 Per Share
ABSECON, N.J., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Absecon Bancorp (the “Company”) (OTC, trading as ASCN), the bank holding company of First National Bank of Absecon, an Atlantic County New Jersey based community bank, announced today that its Board of Directors declared a regular quarterly cash dividend in the amount of $1.05 per share, payable on December 30, 2025 to shareholders of record as of December 16, 2025.
...keep reeding on globenewswire.com
Magnum Ice Cream CEO Backs RFK Jr.'s ‘Healthy America' Push
New chief executive Peter ter Kulve said he is aligned with the Make America Healthy Again movement, endorsing the push for higher-quality foods despite selling high-calorie products.
...keep reeding on wsj.com
Rubrik Stock Soars After Strong Q3 Earnings
Rubrik Inc (NYSE:RBRK) stock is soaring today, last seen up 24.6% at $87.82, after the cloud data management company reported better-than-expected third-quarter earnings and revenue and trimmed its full-year loss forecast.
...keep reeding on schaeffersresearch.com
Campbell's Readies for Q1 Earnings: Things to Watch for CPB Stock
CPB faces tariff pressures and higher marketing costs, while steady at-home cooking may boost its Meals & Beverages results.
...keep reeding on zacks.com
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. VRT, EXPE, NVDA and RL are some such stocks.
...keep reeding on zacks.com
Wall Street Analysts Think Mineralys Therapeutics, Inc. (MLYS) Could Surge 27.55%: Read This Before Placing a Bet
The mean of analysts' price targets for Mineralys Therapeutics, Inc. (MLYS) points to a 27.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
...keep reeding on zacks.com
Wall Street Analysts See a 63.99% Upside in Pagaya Technologies Ltd. (PGY): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 64% in Pagaya Technologies Ltd. (PGY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
...keep reeding on zacks.com
How Much Upside is Left in Sprinklr (CXM)? Wall Street Analysts Think 32.91%
The mean of analysts' price targets for Sprinklr (CXM) points to a 32.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
...keep reeding on zacks.com
Should You Buy Si-Bone (SIBN) After Golden Cross?
After reaching an important support level, SiBone (SIBN) could be a good stock pick from a technical perspective. SIBN recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
...keep reeding on zacks.com
Wall Street Analysts See a 29.72% Upside in Archer Aviation (ACHR): Can the Stock Really Move This High?
The mean of analysts' price targets for Archer Aviation (ACHR) points to a 29.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
...keep reeding on zacks.com
Transportadora De Gas Sa Ord B (TGS) Just Flashed Golden Cross Signal: Do You Buy?
Transportadora De Gas Sa Ord B (TGS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TGS's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
...keep reeding on zacks.com
Wall Street Analysts Think Profound Medical (PROF) Could Surge 82.37%: Read This Before Placing a Bet
The consensus price target hints at an 82.4% upside potential for Profound Medical (PROF). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
...keep reeding on zacks.com
ATN International (ATNI) Just Flashed Golden Cross Signal: Do You Buy?
From a technical perspective, ATN International, Inc. (ATNI) is looking like an interesting pick, as it just reached a key level of support. ATNI's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.
...keep reeding on zacks.com
Does Theravance Bio (TBPH) Have the Potential to Rally 30.64% as Wall Street Analysts Expect?
The consensus price target hints at a 30.6% upside potential for Theravance Bio (TBPH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
...keep reeding on zacks.com
Wall Street Analysts Think Atlassian (TEAM) Could Surge 50.43%: Read This Before Placing a Bet
The mean of analysts' price targets for Atlassian (TEAM) points to a 50.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
...keep reeding on zacks.com
Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's What You Should Know
The mean of analysts' price targets for Benitec Biopharma (BNTC) points to an 87.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
...keep reeding on zacks.com